Molecular inhibition of angiogenesis and metastatic potential in human squamous cell carcinomas after epidermal growth factor receptor blockade. [electronic resource]
- Molecular cancer therapeutics May 2002
- 507-14 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1535-7163
Animals Antibodies, Monoclonal--therapeutic use Antibodies, Monoclonal, Humanized Carcinoma, Squamous Cell--metabolism Cell Movement Cells, Cultured Cetuximab Chemotaxis Collagen--pharmacology Dose-Response Relationship, Drug Down-Regulation Drug Combinations Endothelium, Vascular--cytology Epidermal Growth Factor--metabolism Extracellular Matrix--metabolism Fibronectins--metabolism Head and Neck Neoplasms--metabolism Humans Immunohistochemistry Laminin--pharmacology Matrix Metalloproteinase 9--metabolism Mice Neoplasm Invasiveness Neoplasm Metastasis Neoplasm Transplantation Neovascularization, Pathologic Proteoglycans--pharmacology Time Factors Tumor Cells, Cultured